What does Ibis Pharma do?
IBIS PHARMA specializes in providing innovative solutions for drug development and regulatory affairs. The company offers a range of services including project management, clinical trial support, and regulatory submission guidance. Their expertise helps clients streamline the path to market for new pharmaceuticals.
- Sectors
- Pharmacies Wholesalers
- Signals
-
ProfitableProfitable € 562K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 3.95MStrong equity provides a buffer against setbacks.
Low riskLow risk 67.1%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 3.00A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 585KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 798KPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 16.91MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 12.0%Social debts stay manageable relative to personnel costs.
- Shareholders
- Nyota Invest 99,92%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
16.91M
|
€
17.86M
|
€
15.96M
|
|
|
|
€
798K
|
€
949K
|
€
628K
|
€
875K
|
|
|
€
562K
|
€
685K
|
€
441K
|
€
676K
|
|
|
€
3.95M
|
€
3.39M
|
€
3.40M
|
€
3.26M
|
|
|
67.11%
|
51.69%
|
58.69%
|
52.15%
|
|
|
€
1.94M
|
€
3.17M
|
€
2.40M
|
€
2.99M
|
|
|
€
1.62M
|
€
945K
|
€
1.15M
|
€
955K
|
|
|
5.80
|
6
|
6
|
6
|
Publications 30
All publications- Demissions, Nominations 12/06/2026
- Statuts (Traduction, Coordination, Autres Modifications, ?) - Siege Social - Demissions, Nominations 22/09/2025
- Rubrique Fin (Cessation, Annulation Cessation, Nullite, Conc, Reorganisation Judiciaire, Etc...) 12/02/2024
- Me. - Comptes Annuels 31.12.2015, App 03.05.2016, Dpt 13.07.2016 16321-0423-036 22/07/2016
- Demissions, Nominations 14/07/2016
Frequently asked questions
Answers to the most common questions about Ibis Pharma, based on official government data and the filed annual accounts.
What is the VAT number of Ibis Pharma?
The VAT number of Ibis Pharma is BE0448.505.234.
How many employees work at Ibis Pharma?
In 2025, Ibis Pharma employed 5.80 full-time equivalents (FTE).
When was Ibis Pharma established?
Ibis Pharma was founded in 27-10-1992.
What is the official address of Ibis Pharma?
The official address of Ibis Pharma is Rue Du Basteau,Forrières 5 Nassogne 6953.
What is the legal form of Ibis Pharma?
The juridical form of Ibis Pharma is Public limited company (NV/SA).
What is the annual revenue of Ibis Pharma?
The revenue of Ibis Pharma for the 2025 financial year was €16,914,169.
What does Ibis Pharma do?
IBIS PHARMA specializes in providing innovative solutions for drug development and regulatory affairs. The company offers a range of services including project management, clinical trial support, and regulatory submission guidance. Their expertise helps clients streamline the path to market for new pharmaceuticals.
Is Ibis Pharma a reliable company?
Ibis Pharma is a registered Rechtspersoon with company number 0448.505.234 and can be verified through the official CBE database.
What is the credit limit of Ibis Pharma?
The estimated credit limit of Ibis Pharma is €1,920,611.
Is Ibis Pharma still active?
Ibis Pharma currently has the status "Normal situation" and is active.